Inflammation is a significant component of several chronic diseases involving the cardiovascular, metabolic, musculoskeletal, and nervous systems. Timely identification and localization of inflammation is critical for the adequate treatment of patients. Notably, also, infection always has inflammatory components. Molecular imaging such as positron emission tomography (PET) may reveal molecular and cellular changes and provide sensitive detection of inflammatory and/or infectious foci at an early stage of disease. In general, specific imaging of inflammatory processes may be a demanding task because of increased blood flow and enhanced vascular permeability causing unspecific uptake of imaging agents. Although several radiopharmaceuticals have been developed, no agent has been found with the optimal characteristics for imaging inflammation, and thus, there is still room for new, better agents and development of quantification methods.
is special issue consists of totally 11 articles (147 pages) including three review articles, six research articles, and two clinical studies. Nine articles are dealing with PET, one with magnetic resonance imaging (MRI), and one with PET-MRI. One of the research article deals with the modeling of PET, and the rest are preclinical/translational studies.
To perform diagnosis with PET, appropriate radiopharmaceuticals are needed. e radiopharmaceuticals are compounds possessing positron-emitting radionuclides, and gallium-68 ( 68 Ga) is one of the most frequently used radionuclides in clinical PET. e review article "Prospective of 68 Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation" by Velikyan provides an overview of 68 Ga-labelled compounds for imaging of inflammation and infection in both preclinical and clinical settings. 68 Ga can be conveniently obtained from commercially available generators, which facilitates the implementation of 68 Ga-radiopharmaceutical research in many medical centers and in major human diseases including infection and inflammation.
In neuroinflammatory diseases such as multiple sclerosis (MS Another important target for PET imaging of inflammation is 18 kDa translocator protein (TSPO). In the paper "TSPO PET Imaging: from Microglial Activation to Peripheral Sterile Inflammatory Diseases?" by Largeau et al., the authors discuss the exciting findings so far observed in the research of TSPO-targeted imaging. Furthermore, the challenges related to TSPO expression under physiological conditions and radioligand metabolism have been presented.
Fluorine-18 is a frequently used radionuclide for PET imaging, and its nonradioactive isotope fluorine-19 ( Osteomyelitis is an infectious bone disease, and PET imaging of osteomyelitis is often challenging, in particular in the cases of altered bone structures. Crohn's disease is a chronic inflammatory disease that can affect the entire gastrointestinal track. To increase the accuracy in assessing Crohn's disease, Domachevsky et al. have added an apparent diffusion coefficient and a metabolic inflammatory volume to the magnetic resonance index of the activity score, and this has been described in their paper "Correlation of is special issue presents some new evidences of preclinical and clinical PET imaging of inflammation and infection, in addition to the overviews highly relevant to this field. We hope that this issue will provoke further research on these topics.
